Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience
暂无分享,去创建一个
B. Merkely | A. Kosztin | L. Molnár | L. Geller | I. Osztheimer | E. Zima | A. Kovács | M. Tokodi | A. Behon | W. Schwertner | E. Merkel | Á. Király | R. Papp | L. Kuthi | Boglárka Veres | B. Veres | L. Gellér
[1] B. Merkely,et al. Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score , 2020, European heart journal.
[2] K. Dickstein,et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II , 2018, European journal of heart failure.
[3] J. Panting,et al. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy , 2018, Pacing and clinical electrophysiology : PACE.
[4] B. Merkely,et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis , 2017, Heart Failure Reviews.
[5] R. Swaminathan,et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013. , 2017, Heart rhythm.
[6] C. Israel,et al. Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study , 2017, Circulation. Arrhythmia and electrophysiology.
[7] G. Hindricks,et al. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] K. Srivathsan,et al. Short-term outcome of cardiac resynchronization therapy - a comparison between newly implanted and chronically right ventricle-paced patients. , 2016, International journal of cardiology.
[9] W. D. de Voogt. Upgrading and replacement in CRT devices: experience counts , 2015, Netherlands Heart Journal.
[10] A. Vallakati,et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] J. Healey,et al. Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy: The RAFT Upgrade Substudy , 2015, Circulation. Arrhythmia and electrophysiology.
[12] Lluís Mont,et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] K. Dickstein,et al. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades , 2011, European journal of heart failure.
[14] M. Chung,et al. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.
[15] H. Wiste,et al. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. , 2009, Heart rhythm.
[16] M. Castel,et al. Hemodynamics and Prognosis after Primary Cardiac Resynchronization System Implantation Compared to “Upgrade” Procedures , 2008, Pacing and clinical electrophysiology : PACE.
[17] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[18] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[19] J. Daubert,et al. Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). , 2003, The American journal of cardiology.
[20] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[21] C. Winearls,et al. Ageing and the glomerular filtration rate: truths and consequences. , 2009, Transactions of the American Clinical and Climatological Association.